N@N

Rockwell Medical Technologies Inc (NASDAQ:RMTI), Down By 7.09% ($0.31) From $4.359 After BUYINS.NET Report Predicted Weakness

^{Published on 2013-03-19 07:45:46 - WOPRAI}
 

March 19, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Friday, March 15th 2013 stating that Rockwell Medical Technologies Inc (NASDAQ:RMTI) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=rmti&id=354496

At the time this story was written, Rockwell Medical Technologies Inc (NASDAQ:RMTI) is Down By 7.09% ($0.31) From $4.359 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Rockwell Medical Technologies Inc (NASDAQ:RMTI) - Rockwell Medical, Inc., an integrated biopharmaceutical company, engages in the manufacture, sale, and distribution of hemodialysis concentrates/dialysates targeting the end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally. Its products include Renal Pure and CitraPure liquid acid concentrate, Dri-Sate dry acid concentrate and mixing systems, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrates; and various ancillary products comprising blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies. The company is also developing generic version of calcitriol, a vitamin D analogue for the treatment of secondary hyperparathyroidism. Its lead drug candidate is soluble ferric pyrophosphate, which is in Phase III clinical trials, for use in the formation of new red blood cells to treat iron deficiency in anemia dialysis patients. Rockwell Medical, Inc. sells its products to hemodialysis providers and distributors through direct sales people and independent sales agents. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in 2012. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Rockwell Medical Technologies Inc (NASDAQ:RMTI) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net